NYSE Content Advisory: Pre-Market update + Wall Street braces for Nvidia’s earnings
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- The New York Stock Exchange…
Abbott receives regulatory approval for the first denosumab biosimilar in Thailand, expanding access to bone disease treatment
Abbott'sĀ denosumab biosimilar is the first approved in Thailand, making advanced therapy for…
Anbogen Receives FDA Clearance to Initiate Phase 1/2 Trial of ABT-301 Triplet Therapy for Advanced Colorectal Cancer
TAIPEI, Aug. 4, 2025 /PRNewswire/ -- Anbogen Therapeutics today announced that the…